Synthetic organic

InformationGSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.TargetsRIP1 kinase (Cell-free assay) 6.3 nMIn vitroGSK3145095 potently binds to

InformationGSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.TargetsRIP1 kinase (Cell-free assay) 6.3 nMIn vitroGSK3145095 potently binds to

InformationGSK3145095 GSK3145095 is a potent and orally active RIP1 kinase inhibitor with IC50 of 6.3 nM with potential antineoplastic and immunomodulatory activities.TargetsRIP1 kinase (Cell-free assay) 6.3 nMIn vitroGSK3145095 potently binds to

GSK329.

GSK329.

GSK334429.

GSK334429.

It is an epigenetic chemical probe available through a partnership between Sigma Life Science and the Structural Genomics Consortium (SGC).An inhibitor of the histone lysine methyltransferase ENX-1.

It is an epigenetic chemical probe available through a partnership between Sigma Life Science and the Structural Genomics Consortium (SGC).An inhibitor of the histone lysine methyltransferase ENX-1.

It is an epigenetic chemical probe available through a partnership between Sigma Life Science and the Structural Genomics Consortium (SGC).An inhibitor of the histone lysine methyltransferase ENX-1.

GSK3527497.

GSK3527497.